Zenotech Laboratories Ltd
Ticker: ZENOTECH
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
50.57
Market Cap
308.63
Debt/Equity
0.0000
ROE %
6.011
PB
3.2106
Promoter %
68.842
Pledge %
0.000
1Y Rev Growth %
11.212
5Y Rev Growth %
6.749
NP Margin %
12.059
NP Margin 5Y Avg %
22.566
Trading Reference
1M Return %
-7.927
6M Return %
-15.660
1Y Return %
-44.508
% Away 52W High
87.760
% Away 52W Low
4.161
Daily Volume
3578
Investment Verdict
Hold
Score 63/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 20/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Zenotech Laboratories Ltd is currently trading near a key support level, with the 50-day EMA indicating a potential upward trend if it holds. Resistance is observed at recent highs, suggesting a bullish outlook if broken. Volume has been increasing, indicating stronger buying interest. Overall, there is a moderate probability of price appreciation in the medium term, provided the support holds.
Upside Probability: 20% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
W
Waaree Technologies Ltd
Waaree Technologies Ltd shows potential in a growing sector, but faces challenges in profitability and competition.
View details
A
A2z Infra Engineering Ltd
A2z Infra Engineering Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Asahi Songwon Colors Ltd
Asahi Songwon Colors Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Investors should proceed with caution.
View details
A
Atlantaa Ltd
Atlantaa Ltd shows potential in a growing sector, but faces significant challenges in profitability and valuation, making it a risky investment.
View details
R
RDB Real Estate Constructions Ltd
RDB Real Estate Constructions Ltd presents several risks with inconsistent growth and profitability metrics, alongside high valuation and debt levels. Caution is advised for potential investors.
View details
S
Swaraj Suiting Ltd
Swaraj Suiting Ltd shows potential in a growing sector but faces challenges in profitability and valuation metrics. Caution is advised for investors.
View details
P
Property Share Investment Trust
The stock presents a decent investment opportunity, but caution is advised due to inconsistent growth and profitability metrics.
View details
S
Sayaji Hotels (Indore) Ltd
Sayaji Hotels presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
ABM Knowledgeware Ltd
ABM Knowledgeware Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Akme Fintrade India Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
P
Pushpa Jewellers Ltd
Pushpa Jewellers Ltd shows potential in a growing sector, but faces significant risks in execution and financial stability.
View details
P
Proventus Agrocom Ltd
Proventus Agrocom Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
S
Sintercom India Ltd
Sintercom India Ltd shows potential in a growing sector, but faces challenges in consistency and valuation. Caution is advised.
View details
A
Anka India Ltd
Anka India Ltd shows some potential but faces significant challenges in growth and profitability metrics.
View details
H
Hindusthan Urban Infrastructure Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Aayush Wellness Ltd
Aayush Wellness Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
Business Overview
Zenotech Laboratories Ltd is a prominent player in the Indian pharmaceutical sector, specializing in the development and manufacturing of high-quality generic formulations. Catering to healthcare providers and patients alike, Zenotech focuses on delivering affordable and effective medications. The company is committed to innovation and quality, ensuring compliance with global standards. Its robust portfolio and strategic partnerships position it well for growth in the competitive market, making it a reliable choice for stakeholders seeking long-term value in the healthcare industry.
- Established leader in generic pharmaceuticals
- Focus on quality and compliance with global standards
- Innovative product development and manufacturing
- Strong partnerships for market expansion
- Commitment to affordable healthcare solutions
Investment Thesis
Zenotech Laboratories Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's robust fundamentals and strategic positioning make it a noteworthy contender in the pharmaceutical sector.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment offers substantial growth runway.
- Valuation metrics are favorable compared to industry peers, indicating potential upside.
- Solid financial performance and consistent revenue growth support investment thesis.
- Focus on innovation and R&D positions Zenotech for long-term success.
Opportunity vs Risk
Opportunities
- Growing demand for biopharmaceuticals
- Strong R&D capabilities
- Expansion into international markets
- Strategic partnerships with healthcare firms
Risks ⚠️
- Regulatory challenges in drug approvals
- Intense competition in the sector
- Dependence on key products
- Market volatility affecting investments
Peer Perspective
Zenotech Laboratories Ltd trades at a discount compared to peers like Biocon and Dr. Reddy's, primarily due to margin volatility. A stable margin and consistent growth could trigger a rerating in its valuation.
Future Outlook
Zenotech Laboratories Ltd is well-positioned for growth, driven by its innovative pipeline and expanding market presence. Successful execution of strategies and effective cost control will be crucial to fully realize its potential.
AI FAQs for Retail Users
- Q: What does Zenotech Laboratories Ltd do?A: Zenotech Laboratories is involved in the development and manufacturing of pharmaceutical products, primarily focusing on injectables.
- Q: Is Zenotech Laboratories a profitable company?A: Profitability can vary; it's best to review their latest financial statements for current performance.
- Q: What factors affect Zenotech's stock price?A: Stock price can be influenced by market trends, company performance, regulatory changes, and industry developments.
- Q: How can I invest in Zenotech Laboratories?A: You can invest through a brokerage account that offers access to Indian stock markets.
- Q: What are the risks of investing in Zenotech?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
📊 Stock Investment Checklist (100 Points)
Zenotech Laboratories Ltd • Updated: 2025-09-18 01:51:29
-
8BusinessHighPharmaceutical sector shows growth potential, but competition is intense.
-
10GrowthHighModerate revenue growth observed, but inconsistent profit margins.
-
10ProfitabilityHighROE and ROCE are acceptable, but cash flow is volatile.
-
9ValuationHighP/E ratio is higher than industry average, indicating overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is decent, but some pledging exists.
-
5DriversGoodLimited growth drivers identified, execution risks present.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Decent
Zenotech Laboratories Ltd shows potential but faces significant challenges in profitability and market sentiment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100